‘Tumor paint’ could help surgeons treat brain cancer

Tumor paint, a substance derived from scorpion venom that can cross the blood-brain barrier, can make brain tumors glow under near-infrared light, making them easier targets for surgeons.

Human trials with tumor paint are currently underway at Cedars Sinai Medical Center in Los Angeles. For more on this research, check out the report from NPR at the link below: 

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.